Mounjaro 10mg Tirzepatide Injection
Mounjaro 10mg is a prescription injectable medicine containing Tirzepatide, an advanced dual GIP and GLP-1 receptor agonist designed for adults managing type 2 diabetes mellitus. By activating both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) hormone receptors, Mounjaro provides a dual-action mechanism that enhances insulin release, suppresses liver glucos
- Estimated Delivery : Up to 4 business days
- Free Shipping & Returns : On all orders over $200
Mounjaro 10mg is a prescription injectable medicine containing Tirzepatide, an advanced dual GIP and GLP-1 receptor agonist designed for adults managing type 2 diabetes mellitus. By activating both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) hormone receptors, Mounjaro provides a dual-action mechanism that enhances insulin release, suppresses liver glucose output, and slows digestion to aid glycemic and appetite control.
Key Benefits
- Glycemic Control: Helps significantly lower blood glucose and HbA1c levels.
- Appetite & Weight Management: Slows gastric emptying and reduces appetite to support metabolic health.
- Once-Weekly Dosing: Administered as a convenient once-weekly subcutaneous injection.
Storage Instructions
Store refrigerated between 2°C and 8°C (36°F to 46°F). Do not freeze and protect from direct light. If necessary, pens may be kept at room temperature up to 30°C (86°F) for up to 21 days.
| Brand | Mounjaro |
| Generic Name | Tirzepatide |
| Active Ingredient | Tirzepatide |
| Manufacturer | Eli Lilly and Company |
| Drug Class | dual GIP and GLP-1 receptor agonist |
| Strength | 10 mg |
| Dosage Form | Injectable Pen |
| Packaging | 1 weekly Injection Pack |
| Indication | Type 2 Diabetes |
| Brand | Mounjaro |
|---|











Reviews
There are no reviews yet.